Supplementary Figure 1 from Ganetespib, a Unique Triazolone-Containing Hsp90 Inhibitor, Exhibits Potent Antitumor Activity and a Superior Safety Profile for Cancer Therapy

MLA

Keizo Koya, et al. Supplementary Figure 1 from Ganetespib, a Unique Triazolone-Containing Hsp90 Inhibitor, Exhibits Potent Antitumor Activity and a Superior Safety Profile for Cancer Therapy. Apr. 2023. EBSCOhost, https://doi.org/10.1158/1535-7163.22499515.

APA

Keizo Koya, James Barsoum, Yumiko Wada, Luisa Shin Ogawa, Jamie Acquaviva, Shuxia Ye, Jim Sang, Noriaki Tatsuta, Takayo Inoue, Dan Zhou, Ronald K. Blackman, David A. Proia, Kevin P. Foley, Lijun Sun, Zhenjian Du, & Weiwen Ying. (2023). Supplementary Figure 1 from Ganetespib, a Unique Triazolone-Containing Hsp90 Inhibitor, Exhibits Potent Antitumor Activity and a Superior Safety Profile for Cancer Therapy. https://doi.org/10.1158/1535-7163.22499515

Chicago

Keizo Koya, James Barsoum, Yumiko Wada, Luisa Shin Ogawa, Jamie Acquaviva, Shuxia Ye, Jim Sang, et al. 2023. “Supplementary Figure 1 from Ganetespib, a Unique Triazolone-Containing Hsp90 Inhibitor, Exhibits Potent Antitumor Activity and a Superior Safety Profile for Cancer Therapy,” April. doi:10.1158/1535-7163.22499515.